|
OAS3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.229900E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.208400E-04 |
| Normal-vs-Stage2 |
4.957000E-01 |
| Normal-vs-Stage3 |
2.502300E-02 |
| Normal-vs-Stage4 |
1.291370E-01 |
| Stage1-vs-Stage2 |
1.208220E-01 |
| Stage1-vs-Stage3 |
7.135600E-01 |
| Stage1-vs-Stage4 |
9.962600E-01 |
| Stage2-vs-Stage3 |
2.431400E-01 |
| Stage2-vs-Stage4 |
3.261600E-01 |
| Stage3-vs-Stage4 |
8.543600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.224700E-04 |
| Normal-vs-AfricanAmerican |
3.501900E-02 |
| Normal-vs-Asian |
6.343200E-03 |
| Caucasian-vs-AfricanAmerican |
2.774800E-01 |
| Caucasian-vs-Asian |
7.133200E-01 |
| AfricanAmerican-vs-Asian |
4.749200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.994200E-02 |
| Normal-vs-Female |
2.607400E-04 |
| Male-vs-Female |
2.586200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.73879999999916E-05 |
| Normal-vs-Age(41-60Yrs) |
1.221970E-02 |
| Normal-vs-Age(61-80Yrs) |
3.384600E-01 |
| Normal-vs-Age(81-100Yrs) |
4.238400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.211350E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.302500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.181400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.927990E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.166000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.827220E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.733800E-01 |
| Classical-VS-Follicular |
1.62503344114384E-12 |
| Classical-VS-Other |
6.061100E-03 |
| Classical-VS-Normal |
6.33059999977093E-07 |
| Tall-VS-Follicular |
2.816500E-03 |
| Tall-VS-Other |
2.064100E-02 |
| Tall-VS-Normal |
3.523700E-02 |
| Follicular-VS-Other |
9.459600E-01 |
| Follicular-VS-Normal |
9.837900E-03 |
| Other-VS-Normal |
2.894400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.953730E-02 |
| Normal-vs-N1 |
1.718020E-02 |
| N0-vs-N1 |
1.906050E-01 |
|
|
